ImmunityBio Inc (IBRX): Next-Year EPS Estimate 81.57%
As of 2026-06-11, ImmunityBio Inc (IBRX) has a next-year EPS growth estimate of 81.57%.
On 2026-06-11, analyst consensus for IBRX's next-year EPS growth shifted from 84.89% to 81.57% — a negative change of 3.32 percentage points. Current-year growth is projected at -123.68%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 81.57%
- EPS growth this year
- -123.68%
- EPS next quarter (est)
- -$0.09
- Last price
- $7.20
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 81.57% | -123.68% | -$0.09 | $7.20 |
| 2026-06-10 | 84.89% | -82.89% | -$0.08 | $6.98 |
| 2026-06-09 | 84.89% | -82.89% | -$0.08 | $7.25 |
| 2026-06-08 | 84.89% | -82.89% | -$0.08 | $7.17 |
| 2026-06-07 | 84.89% | -82.89% | -$0.08 | $6.92 |
| 2026-06-04 | 84.89% | -82.89% | -$0.08 | $7.29 |
| 2026-06-03 | 84.89% | -82.89% | -$0.08 | $7.18 |
| 2026-06-02 | 84.89% | -82.89% | -$0.08 | $7.23 |
| 2026-06-01 | 84.89% | -82.89% | -$0.08 | $7.24 |
| 2026-05-31 | 84.89% | -82.89% | -$0.08 | $7.52 |
| 2026-05-28 | 92.44% | -87.89% | -$0.08 | $7.72 |
| 2026-05-27 | 92.44% | -87.89% | -$0.08 | $7.89 |
| 2026-05-26 | 92.44% | -87.89% | -$0.08 | $7.92 |
| 2026-05-25 | 92.44% | -87.89% | -$0.08 | $7.22 |
| 2026-05-24 | 92.44% | -87.89% | -$0.08 | $7.22 |
| 2026-05-21 | 92.44% | -87.89% | -$0.08 | $7.74 |
| 2026-05-20 | 92.44% | -87.89% | -$0.08 | $8.05 |
| 2026-05-19 | 92.44% | -87.89% | -$0.08 | $7.76 |
| 2026-05-18 | 92.44% | -87.89% | -$0.08 | $8.00 |
| 2026-05-17 | 92.44% | -87.89% | -$0.08 | $7.97 |
| 2026-05-14 | 92.44% | -87.89% | -$0.08 | $8.15 |
| 2026-05-13 | 92.44% | -87.89% | -$0.08 | $8.10 |
| 2026-05-12 | 92.44% | -87.89% | -$0.08 | $8.12 |
| 2026-05-11 | 92.44% | -87.89% | -$0.08 | $8.11 |
| 2026-05-10 | 91.22% | -60.03% | -$0.08 | $8.51 |
| 2026-05-07 | 77.75% | 32.08% | -$0.07 | $7.76 |
| 2026-05-06 | 77.75% | 32.08% | -$0.07 | $8.38 |
| 2026-05-05 | 77.75% | 32.08% | -$0.07 | $7.58 |
| 2026-05-04 | 77.75% | 32.08% | -$0.07 | $7.43 |
| 2026-05-03 | 77.75% | 32.08% | -$0.07 | $7.11 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is ImmunityBio Inc's next-year EPS growth estimate?▾
As of 2026-06-11, ImmunityBio Inc (IBRX) has a next-year EPS growth estimate of 81.57%, based on analyst consensus.
When was the latest EPS estimate revision for IBRX?▾
The most recent revision occurred on 2026-06-11, when analysts adjusted the next-year EPS growth estimate from 84.89% to 81.57%.
What sector and industry does ImmunityBio Inc belong to?▾
ImmunityBio Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. IBRX appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. ImmunityBio Inc (IBRX) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports